By indication / Receptor expression phenotyping
Receptor expression phenotyping
13 imaging agents and 8 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [68Ga]Ga-Pentixafor paired with [177Lu]Lu-pentixather | Ga-68 | Investigational (academic clinical studies) | 65 |
| [68Ga]Ga-RM2 paired with [111In]In-RM2 | Ga-68 | Clinical research | 15 |
| [18F]FES | F-18 | Approved | 7 |
| [111In]In-RM2 paired with [68Ga]Ga-RM2 | In-111 | Research | 2 |
| [18F]DK222 | F-18 | Research | 2 |
| [68Ga]Ga-ABY-025 | Ga-68 | — | 2 |
| [18F]GE-226 | F-18 | Research | 1 |
| [11C]PS13 | C-11 | first-in-human | 1 |
| [18F]AlF | F-18 | — | 1 |
| [18F]BTK-1 | F-18 | preclinical | 1 |
| [68Ga]Ga-D0103 | Ga-68 | — | 1 |
| [89Zr]Zr-Df-pertuzumab-800CW | Zr-89 | — | 1 |
| [18F]AH113804 | F-18 | Research |
Therapy
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [225Ac]Ac-225-PRIT | Ac-225 | preclinical study | 3 |
| [212Pb]Pb-DOTAMTATE | Pb-212 | preclinical | 3 |
| [68Ga]PKB3 | Ga-68 | Reported once | 1 |
| [89Zr]DFO-11E10C11 | Zr-89 | Reported once | 1 |
| [68Ga]TATE-46 | Ga-68 | preclinical study | 1 |
| [18F]AlF-RESCA-5F7 | F-18 | Reported once | 1 |
| [68Ga]TacBOMB2 | Ga-68 | Reported once | 1 |
| [68Ga]C803-GIP | Ga-68 | Reported once | 1 |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch